Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Head and Neck Cancers
•
Radiation Oncology
How do you manage HPV positive squamous cell carcinoma in situ of the oropharynx?
Answer from: Radiation Oncologist at Academic Institution
transoral surgery
Sign in or Register to read more
3210
Related Questions
In light of de-escalation data, for patients undergoing standard dose radiation for favorable HPV + oropharynx cancer, do you accept lower coverage of the low-dose RT field to better spare OARS?
What would be your approach to the treatment of limited stage extrapulmonary small cell carcinoma of the nasopharynx with bilateral cervical lymphadenopathy?
For HPV-negative head and neck cancer of unknown primary after proper work up and biopsies, what mucosal surface(s) do you cover?
How would you treat a patient with p16 (-) neck lymph node metastasis of an unknown primary, considering their history of prior supraclavicular and chest wall irradiation?
When treating sinonasal undifferentiated carcinoma (SNUC) with induction chemotherapy followed by definitive chemoradiation, do you include the entire pre-chemo volume in your high-dose CTV?
How do you manage the thickened secretions secondary to xerostomia during head and neck radiation?
What dose/fractionation would you use for a multiply recurrent and now unresectable ameloblastoma involving the masticator space, pterygopalatine fossa, and right maxillary sinus?
How would you approach new dermal mets in a patient who recently finished chemoradiation for head and neck SCC?
Do you offer neoadjuvant radiation therapy for oral cavity sarcoma?
What factors would prompt you to offer post-operative RT in early-stage (T1-2N0) nasal cavity squamous cell carcinoma?